DCF — HAYS MEDICAL CENTER INC.
Enterprise Value: $-409.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-409.7M
Enterprise Value
$-128.4M
PV of Cash Flows
$-281.2M
PV of Terminal Value
$-452.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $221.6M | $-26.2M | -12.0% | $-35.5M | $-32.3M |
| Year 2 | $228.2M | $-24.7M | -11.0% | $-34.3M | $-28.4M |
| Year 3 | $235.1M | $-23.1M | -10.0% | $-33.0M | $-24.8M |
| Year 4 | $242.1M | $-22.5M | -9.0% | $-32.8M | $-22.4M |
| Year 5 | $249.4M | $-22.6M | -9.0% | $-33.1M | $-20.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-409.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$215.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12306303180896007
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5